Encouraging late-stage trial results from Pfizer and Moderna have set a high bar on the Covid-19 vaccine race.
— Bloomberg (@business) November 16, 2020
Here’s what we know about the two shots https://t.co/URvQKfujz6
Monday, November 16, 2020
Encouraging late-stage trial results from Pfizer and Moderna have set a high bar on the Covid-19 vaccine race. Here’s what we know about the two shots
